title: Does the presence of aura inform us regarding migraine severity and response to treatment?
authors.affiliation: From the Department of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH. thomas.n.ward@hitchcock.org.
authors.forename: Thomas N
authors.initials: TN
authors.lastname: Ward
mesh_terms: D004087:Dihydroergotamine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D020325:Migraine with Aura / Q000188:drug therapy*; D020326:Migraine without Aura / Q000188:drug therapy*; D018170:Sumatriptan / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
chemical_list: D014662:Vasoconstrictor Agents; D004087:Dihydroergotamine; D018170:Sumatriptan